Literature DB >> 18922582

Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors.

Stefan Klingberg1, Sabine Schneider, Andreas Wittorf, Gerhard Buchkremer, Georg Wiedemann.   

Abstract

Knowledge of factors relevant for medication adherence and patient collaboration is still limited. Our study aims at exploring the contribution of a variety of factors to collaboration in outpatients with schizophrenia and schizoaffective disorder. We obtained self-rated and observer-rated data from 108 outpatients during an interview 6 months after hospital discharge. The compliance rating scale (CRS) classified 76% of the patients as collaborative. Factors related to the patient, illness, treatment, and social environment were analysed in two-step explorative correlation and regression analyses in order to determine their relative contribution to collaboration. Only trust in medication and lack of insight were associated with collaboration, and they accounted for 38% of the variance. Neither medication side effects nor neuropsychological functioning correlated with collaboration. The conceptualisation of medication adherence is complex, and there are a number of unresolved methodological problems. The data indicate that illness and treatment-related subjective attitudes may be more relevant than side effects, cognitive functioning or any sociodemographic variable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922582     DOI: 10.1016/j.psychres.2007.07.027

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

2.  Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Authors:  Richard J Drake; Merete Nordentoft; Gillian Haddock; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Marion Leboyer; Stefan Leucht; Markus Leweke; Phillip McGuire; Andreas Meyer-Lindenberg; Dan Rujescu; Iris E Sommer; René S Kahn; Shon W Lewis
Journal:  Schizophr Bull       Date:  2015-03-05       Impact factor: 9.306

3.  Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.

Authors:  Susanne Steinlechner; Christine Klein; Andreas Moser; Rebekka Lencer; Johann Hagenah
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

4.  The validity and Reliability of the Turkish Version of Drug Attitude Inventory-10.

Authors:  Emine Aydin; Erkan Aydin; Özlem Devrim Balaban; Hüseyin Yumrukçal; Murat Erkiran
Journal:  Noro Psikiyatr Ars       Date:  2018-06-04       Impact factor: 1.339

5.  Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients.

Authors:  Steffen Moritz; Maarten J V Peters; Anne Karow; Azra Deljkovic; Peter Tonn; Dieter Naber
Journal:  Ment Illn       Date:  2009-12-17

6.  The Effect of Group Psychoeducation Program on Medication Adherence in Patients with Bipolar Mood Disorders: a Randomized Controlled Trial.

Authors:  Farnaz Rahmani; Hossein Ebrahimi; Fatemeh Ranjbar; Seyed Sajjad Razavi; Elnaz Asghari
Journal:  J Caring Sci       Date:  2016-12-01

7.  Attitude Towards Drug Therapy in a Community Mental Health Center Evaluated by the Drug Attitude Inventory.

Authors:  Rosaria Di Lorenzo; Daniela Perrone; Anushree Montorsi; Jessica Balducci; Sergio Rovesti; Paola Ferri
Journal:  Patient Prefer Adherence       Date:  2020-06-17       Impact factor: 2.711

Review 8.  Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature.

Authors:  Giulia M Giordano; Francesco Brando; Pasquale Pezzella; Maria De Angelis; Armida Mucci; Silvana Galderisi
Journal:  Front Psychiatry       Date:  2022-08-30       Impact factor: 5.435

9.  Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine.

Authors:  Gabriel G Edwards; Ayako Miyashita-Ochoa; Enrico G Castillo; David Goodman-Meza; Ippolytos Kalofonos; Raphael J Landovitz; Arleen A Leibowitz; Craig Pulsipher; Ed El Sayed; Steven Shoptaw; Chelsea L Shover; Michelle Tabajonda; Yvonne S Yang; Nina T Harawa
Journal:  AIDS Behav       Date:  2022-09-05

10.  Can we trust the internet to measure psychotic symptoms?

Authors:  Steffen Moritz; Niels Van Quaquebeke; Tania M Lincoln; Ulf Köther; Christina Andreou
Journal:  Schizophr Res Treatment       Date:  2013-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.